You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hypercholesterolemia, Familial, 3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2 Trial in Moscow (genetic,

Recruiting
  • Hypercholesterolemia, Familial
  • +25 more
  • Genetic Testing
  • +7 more
  • Moscow, Russian Federation
    National Medical Research Centre for Therapy and Preventive Medi
Jul 25, 2022

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

Not yet recruiting
  • Dyslipidemias
  • +4 more
  • Combination Therapy
  • +5 more
  • (no location specified)
Aug 22, 2023

Homozygous Familial Hypercholesterolemia Trial in Beijing (IBI306)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • IBI306
  • Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Sep 12, 2022

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Homozygous Familial Hypercholesterolemia Trial in Australia, Canada, United States (ARO-ANG 3 Injection)

Recruiting
  • Homozygous Familial Hypercholesterolemia
  • ARO-ANG 3 Injection
  • Mount Sinai, New York
  • +7 more
Sep 26, 2022

Familial Hypercholesterolemia, Lipid Disorder Trial in Montreal

Recruiting
  • Familial Hypercholesterolemia
  • Lipid Disorder
    • Montreal, Quebec, Canada
      Research Institute of the McGill University Health Centre: Glen
    Oct 8, 2021

    Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)

    Not yet recruiting
    • Homozygous Familial Hypercholesterolemia
    • NGGT006
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xian Jiaotong University
    Nov 5, 2023

    Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Obicetrapib, Placebo)

    Recruiting
    • Dyslipidemias
    • +8 more
    • Sarasota, Florida
    • +11 more
    Aug 10, 2022

    Homozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep, evolocumab)

    Active, not recruiting
    • Homozygous Familial Hypercholesterolemia
    • Evanston, Illinois
    • +11 more
    Jul 13, 2022

    Familial Hypercholesterolemia, Atherosclerosis Trial (Visualization of coronary Imaging and oral description)

    Not yet recruiting
    • Familial Hypercholesterolemia
    • Atherosclerosis
    • Visualization of coronary Imaging and oral description
    • (no location specified)
    Mar 6, 2023

    Homozygous Familial Hypercholesterolemia Trial (SHR-1918)

    Not yet recruiting
    • Homozygous Familial Hypercholesterolemia
    • (no location specified)
    Aug 22, 2023

    Familial Hypercholesterolemia Trial in Philadelphia (Cascade screening)

    Enrolling by invitation
    • Familial Hypercholesterolemia
    • Cascade screening
    • Philadelphia, Pennsylvania
      University of Pennsylvania, Perelman School of Medicine
    Feb 27, 2023

    Familial Hypercholesterolemia, Cholesterol, Elevated, Genetic Disease Trial in Duluth (Motivational interview (MI))

    Recruiting
    • Familial Hypercholesterolemia
    • +2 more
    • Motivational interview (MI)
    • Duluth, Minnesota
    • +1 more
    Feb 1, 2023

    Familial Hypercholesterolemia Trial in Odense C (Biochemistry interpretive comment on elevated LDL-C levels)

    Not yet recruiting
    • Familial Hypercholesterolemia
    • Biochemistry interpretive comment on elevated LDL-C levels
    • Odense C, Denmark
      Departement of Cardiology, Odense University Hospital
    Nov 10, 2022

    Familial Hypercholesterolemia Trial (phytosterol, krill oil, Placebo phytosterol)

    Not yet recruiting
    • Familial Hypercholesterolemia
    • phytosterol
    • +3 more
    • (no location specified)
    Jan 13, 2023

    Familial Hypercholesterolemia Trial in Philadelphia (Testing centralized referral mechanisms for PCPs, Testing out patient

    Active, not recruiting
    • Familial Hypercholesterolemia
    • Testing centralized referral mechanisms for PCPs
    • Testing out patient outreach methods
    • Philadelphia, Pennsylvania
      University of Pennsylvania Health System
    Feb 17, 2023

    Familial Hypercholesterolemia Trial in Nashville (2-Hydroxybenzylamine, Placebo)

    Not yet recruiting
    • Familial Hypercholesterolemia
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Nov 4, 2022

    Patients With High Cholesterol and Normal Volunteers

    Completed
    • Homozygous Familial Hypercholesterolemic
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 12, 2023

      Severe Familial Hypercholesterolemia Trial in Worldwide (Evolocumab)

      Completed
      Has Results
      • Severe Familial Hypercholesterolemia
      • Evolocumab
      • Los Angeles, California
      • +43 more
      Nov 3, 2022

      Homozygous Familial Hypercholesterolemia Trial (Evinacumab)

      Not yet recruiting
      • Homozygous Familial Hypercholesterolemia
      • (no location specified)
      Nov 3, 2022

      Dyslipidemias, Familial Hypercholesterolemia, Hypertriglyceridemia Trial in Australia, New Zealand (ARO-ANG3, sterile normal

      Completed
      • Dyslipidemias
      • +2 more
      • Camperdown, New South Wales, Australia
      • +5 more
      Sep 20, 2021

      Familial Hypercholesterolemia Trial in Madrid (Alirocumab)

      Completed
      • Familial Hypercholesterolemia
      • Madrid, Spain
        Fundacion Hipercolesterolemia Familiar
      Jul 15, 2022

      Familial Hypercholesterolemia Trial

      Not yet recruiting
      • Familial Hypercholesterolemia
        • (no location specified)
        Apr 11, 2023

        Heterozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep)

        Active, not recruiting
        • Heterozygous Familial Hypercholesterolemia
        • Cincinnati, Ohio
        • +6 more
        Nov 3, 2022